6124 SARS-CoV-2 S1 IgA
Intended Use:
The AESKULISA SARS-CoV-2 S1 IgA test is a qualitative and quantitative immunoassays for the demonstration of human IgA antibodies in serum or plasma directed against the S1 domain of the spike protein of SARS-CoV-2. The AESKULISA SARS-CoV-2 S1 IgA test assists in the detection of acute infections.
Recombinant Antigens:
Recombinant S1 domain of the spike protein of SARS-CoV-2
Native Antigens:
n.a.
Published in
Infectious Serology ELISA Test Kits
Tagged under